We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.375 | -2.31% | 15.875 | 15.50 | 16.25 | 16.25 | 15.625 | 16.25 | 408,238 | 15:11:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -12.50 | 36.74M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/11/2024 09:11 | Perhaps they meant 5.5 ? | kreature | |
05/11/2024 09:03 | Maker having a day off? | putinaire | |
04/11/2024 21:35 | Sorry, buyers | putinaire | |
04/11/2024 21:35 | Yes stunning publicity. The daily trade count average will rocket up,, Sellers | putinaire | |
04/11/2024 21:27 | 200k was well worth it for entertainment purposes imv. Plus good publicity if any new investors want to consider getting shafted ? | kreature | |
04/11/2024 20:14 | When you start getting into millions over time, translating to near term multi million pound losses, it all looks rather tempting Be understandable if costs were real, but when you see others coming up with 200K legal bill for a coffee and a natter, you start to wonder | putinaire | |
04/11/2024 20:06 | I was also going to tag revenue forecasts on to future years and earnouts etc, but im thinking JPM have it done already | putinaire | |
04/11/2024 20:02 | Oh that JPM. yes about to sign it all off id say | putinaire | |
04/11/2024 20:01 | JPM prob just doing the paperwork before investing millions here ? | kreature | |
04/11/2024 19:32 | Great short price tbf. | putinaire | |
04/11/2024 19:07 | Then il give mine based upon forecasted revenue growth using past estimated margins, and earnouts lol | putinaire | |
04/11/2024 19:04 | June 2023 Loss for the year (2,835,149) As of June 2023 - retained earnings (9,441,546) Significant improvements in a few days? Or, do we wait for that until H2 next year, as per norm? Would anyone like to give me a forecast for the two above numbers re end of November 2024 AND Nov 2025 | putinaire | |
04/11/2024 19:00 | June 2023 Loss for the year (2,835,149) As of June 2023 - retained earnings (9,441,546) Ummmm the long term loss doesnt seem to be paying off recently Better at the end of the month? Listed April 2017 Would we get away with just calling it an acorn now? Transitioning> Into.,..something?.. | putinaire | |
04/11/2024 18:40 | Not sure but are certain flexible accounting treatments and JIT cash raises really a good way to say shareholder equity is not negative? think bigger institutions would have a frown about that | putinaire | |
04/11/2024 18:34 | Are we still in negative shareholder equity here? I just saw a forecast of revenues growth expected at 160%. But when you look at past revenues and the costs , isnt that simply an increase in losses? | putinaire |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions